SAM
FLGT icon

Shell Asset Management’s Fulgent Genetics FLGT Stock Holding History

Shell Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$72K Sell
3,171
-4,115
-56% -$84.7K 0.01% 754
2025
Q2 		$145K Sell
7,286
-1,804
-20% -$35.2K 0.01% 872
2025
Q1 		$154K Sell
9,090
-384
-4% -$6.54K 0.01% 879
2024
Q4 		$175K Hold
9,474
– – 0.01% 880
2024
Q3 		$206K Buy
+9,474
New +$212K 0.01% 819
2024
Q1 		$192K Sell
9,809
-988
-9% -$24.5K 0.01% 836
2023
Q4 		$312K Sell
10,797
-3,235
-23% -$86.6K 0.01% 701
2023
Q3 		$375K Sell
14,032
-244
-2% -$8.33K 0.02% 680
2023
Q2 		$529K Sell
14,276
-2,290
-14% -$79.8K 0.02% 552
2023
Q1 		$517K Buy
16,566
+12,815
+342% +$412K 0.02% 547
2022
Q4 		$112K Sell
3,751
-763
-17% -$27.3K ﹤0.01% 1125
2022
Q3 		$172K Buy
4,514
+954
+27% +$47.8K 0.01% 1061
2022
Q2 		$194K Buy
3,560
+1,143
+47% +$62.8K 0.01% 1128
2022
Q1 		$151K Sell
2,417
-357
-13% -$23.5K ﹤0.01% 1223
2021
Q4 		$279K Buy
2,774
+13
+0.5% +$1.14K 0.01% 1123
2021
Q3 		$248K Sell
2,761
-120
-4% -$10.9K 0.01% 1139
2021
Q2 		$266K Buy
+2,881
New +$230K 0.01% 1158

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Shell Asset Management's FLGT Position: Q3 2025 in Review

Shell Asset Management reduced its Fulgent Genetics (FLGT) stake by 56% in Q3 2025, selling an estimated $84.7K and leaving 3,171 shares worth $72K. The position accounts for 0.01% of the portfolio, ranked #754.

Shell Asset Management first reported a position in FLGT in Q2 2021 and has held it in 17 quarters since. The position peaked at $529K in Q2 2023. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Shell Asset Management held 3,171 shares of Fulgent Genetics worth $72K as of Q3 2025.
  • Shell Asset Management sold 4,115 Fulgent Genetics shares in Q3 2025, an estimated $84.7K.
  • Fulgent Genetics made up 0.01% of Shell Asset Management's portfolio in Q3 2025, its #754 holding.
  • Shell Asset Management first reported a position in Fulgent Genetics in Q2 2021 and has held it in 17 quarters since.
  • Shell Asset Management's Fulgent Genetics position peaked at $529K in Q2 2023.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.